Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Salvador Guardiola

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Chembiochem : a European Journal of Chemical Biology|June 4, 2019
Enthalpy- versus Entropy-Driven Molecular Recognition in the Era of BiologicsMonica Varese, Salvador Guardiola, Jesús García, et al.
Trends in Pharmacological Sciences|November 11, 2019
A Third Shot at EGFR: New Opportunities in Cancer TherapySalvador Guardiola, Monica Varese, Macarena Sánchez-Navarro, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|January 13, 2011
Synthesis and antiviral evaluation of bisnoradamantane sulfites and related compoundsElena Valverde, Eva Torres, Salvador Guardiola, et al.
Medical Oncology (Northwood, London, England)|September 7, 2022
Anti-EGF nanobodies enhance the antitumoral effect of osimertinib and overcome resistance in non-small cell lung cancer (NSCLC) cellular modelsSalvador Guardiola, Macarena Sánchez-Navarro, Rafael Rosell, et al.
The Journal of Antimicrobial Chemotherapy|August 16, 2022
A new synthetic protegrin as a promising peptide with antibacterial activity against MDR Gram-negative pathogensJavier Moreno-Morales, Salvador Guardiola, Clara Ballesté-Delpierre, et al.
Chemical Science|June 24, 2021
Target-templated <i>de novo</i> design of macrocyclic d-/l-peptides: discovery of drug-like inhibitors of PD-1Salvador Guardiola, Monica Varese, Xavier Roig, et al.
Chembiochem : a European Journal of Chemical Biology|December 18, 2015
Peptides Targeting EGF Block the EGF-EGFR InteractionSalvador Guardiola, Mireia Díaz-Lobo, Jesús Seco, et al.
Pharmaceuticals (Basel, Switzerland)|July 2, 2020
Probing the Kinetic and Thermodynamic Fingerprints of Anti-EGF Nanobodies by Surface Plasmon ResonanceSalvador Guardiola, Monica Varese, Marta Taulés, et al.
Chembiochem : a European Journal of Chemical Biology|July 4, 2019
Protein Chemical Synthesis Combined with Mirror-Image Phage Display Yields d-Peptide EGF Ligands that Block the EGF-EGFR InteractionCristina Díaz-Perlas, Monica Varese, Salvador Guardiola, et al.
Chemical Communications (Cambridge, England)|October 26, 2018
From venoms to BBB-shuttles. MiniCTX3: a molecular vector derived from scorpion venomCristina Díaz-Perlas, Monica Varese, Salvador Guardiola, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Chembiochem : a European Journal of Chemical Biology|June 4, 2019
Enthalpy- versus Entropy-Driven Molecular Recognition in the Era of BiologicsMonica Varese, Salvador Guardiola, Jesús García, et al.
Trends in Pharmacological Sciences|November 11, 2019
A Third Shot at EGFR: New Opportunities in Cancer TherapySalvador Guardiola, Monica Varese, Macarena Sánchez-Navarro, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|January 13, 2011
Synthesis and antiviral evaluation of bisnoradamantane sulfites and related compoundsElena Valverde, Eva Torres, Salvador Guardiola, et al.
Medical Oncology (Northwood, London, England)|September 7, 2022
Anti-EGF nanobodies enhance the antitumoral effect of osimertinib and overcome resistance in non-small cell lung cancer (NSCLC) cellular modelsSalvador Guardiola, Macarena Sánchez-Navarro, Rafael Rosell, et al.
The Journal of Antimicrobial Chemotherapy|August 16, 2022
A new synthetic protegrin as a promising peptide with antibacterial activity against MDR Gram-negative pathogensJavier Moreno-Morales, Salvador Guardiola, Clara Ballesté-Delpierre, et al.
Chemical Science|June 24, 2021
Target-templated <i>de novo</i> design of macrocyclic d-/l-peptides: discovery of drug-like inhibitors of PD-1Salvador Guardiola, Monica Varese, Xavier Roig, et al.
Chembiochem : a European Journal of Chemical Biology|December 18, 2015
Peptides Targeting EGF Block the EGF-EGFR InteractionSalvador Guardiola, Mireia Díaz-Lobo, Jesús Seco, et al.
Pharmaceuticals (Basel, Switzerland)|July 2, 2020
Probing the Kinetic and Thermodynamic Fingerprints of Anti-EGF Nanobodies by Surface Plasmon ResonanceSalvador Guardiola, Monica Varese, Marta Taulés, et al.
Chembiochem : a European Journal of Chemical Biology|July 4, 2019
Protein Chemical Synthesis Combined with Mirror-Image Phage Display Yields d-Peptide EGF Ligands that Block the EGF-EGFR InteractionCristina Díaz-Perlas, Monica Varese, Salvador Guardiola, et al.
Chemical Communications (Cambridge, England)|October 26, 2018
From venoms to BBB-shuttles. MiniCTX3: a molecular vector derived from scorpion venomCristina Díaz-Perlas, Monica Varese, Salvador Guardiola, et al.
Pageof 2